Gastroesophageal reflux (GER) happens when stomach contents come back up into the esophagus. Stomach acid that touches the lining of the esophagus can cause heartburn, also called acid indigestion.

DelveInsight's, “Gastroesophageal Reflux Disease Pipeline Insight, 2025,” report provides comprehensive insights about 10+ companies and 12+ pipeline drugs in Gastroesophageal Reflux Disease (GERD) ...

Gastroesophageal reflux disease (GERD), also known as gastro oesophageal reflux disease, is more than just the occasional heartburn—it’s a chronic condition where stomach acid keeps flowing back into ...

Objective: To investigate the efficacy of acid suppressant drugs in the empirical treatment of gastroesophageal reflux disease (GERD) and in the treatment of endoscopy-negative reflux disease (ENRD).

WILMINGTON, Del.--(BUSINESS WIRE)-- AstraZeneca (NYSE: AZN) announced today that the U.S. Food and Drug Administration (FDA) has approved the use of NEXIUM ® I.V. (esomeprazole sodium) for Injection ...

Five perendoscopic antireflux devices have received Food and Drug Administration (FDA) approval for clinical use since 2000. Two have been subsequently withdrawn from the market by the manufacturers ...

"Gastroesophageal Reflux Disease (GERD) Market"The market for Gastroesophageal Reflux Disease (GERD) is poised for growth during the forecast period (2024-2034), due to escalating prevalence, aging ...

Gastroesophageal reflux disease (GERD) is a common condition in clinical practice, and results from the backward flow of stomach and duodenal contents into the esophagus and higher structures.

The "Gastroesophageal Reflux Disease Therapeutics Market Size, Share & Trends Analysis Report By Drug Type, By Region, And Segment Forecasts, 2025 - 2030" report has been added to ...

Adults prescribed a GLP-1 agent had a 12% higher risk for developing a new chronic cough -- one that persists for over 8 ...